Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

Björn Eliasson; D Möller-Goede; K Eeg-Olofsson; D Wilson; J Cederholm; P Fleck; M Diamant; Marja-Riitta Taskinen; Ulf Smith

doi:10.1007/s00125-011-2447-3

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

Björn Eliasson, D Möller-Goede , K Eeg-Olofsson, D Wilson, J Cederholm, P Fleck, M Diamant, Marja-Riitta Taskinen, Ulf Smith

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Diabetologia
Vuosikerta	55
Numero	4
Sivut	915-925
Sivumäärä	11
ISSN	0012-186X
DOI - pysyväislinkit	https://doi.org/10.1007/s00125-011-2447-3
Tila	Julkaistu - 2012
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3121 Sisätaudit

Pääsy asiakirjaan

10.1007/s00125-011-2447-3

Siteeraa tätä

Eliasson, B., Möller-Goede , D., Eeg-Olofsson, K., Wilson, D., Cederholm, J., Fleck, P., Diamant, M., Taskinen, M-R., & Smith, U. (2012). Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study. Diabetologia, 55(4), 915-925. https://doi.org/10.1007/s00125-011-2447-3

Eliasson, Björn ; Möller-Goede , D ; Eeg-Olofsson, K ; Wilson, D ; Cederholm, J ; Fleck, P ; Diamant, M ; Taskinen, Marja-Riitta ; Smith, Ulf. / Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study. Julkaisussa: Diabetologia. 2012 ; Vuosikerta 55, Nro 4. Sivut 915-925.

@article{4cc55e9e2ddb4cf9bb9ef310a4edb0a9,

title = "Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.",

keywords = "3121 Internal medicine",

author = "Bj{\"o}rn Eliasson and D M{\"o}ller-Goede and K Eeg-Olofsson and D Wilson and J Cederholm and P Fleck and M Diamant and Marja-Riitta Taskinen and Ulf Smith",

year = "2012",

doi = "10.1007/s00125-011-2447-3",

language = "English",

volume = "55",

pages = "915--925",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "4",

}

Eliasson, B, Möller-Goede , D, Eeg-Olofsson, K, Wilson, D, Cederholm, J, Fleck, P, Diamant, M, Taskinen, M-R & Smith, U 2012, 'Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.', Diabetologia, Vuosikerta 55, Nro 4, Sivut 915-925. https://doi.org/10.1007/s00125-011-2447-3

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study. / Eliasson, Björn; Möller-Goede , D; Eeg-Olofsson, K; Wilson, D; Cederholm, J; Fleck, P; Diamant, M; Taskinen, Marja-Riitta; Smith, Ulf.

julkaisussa: Diabetologia, Vuosikerta 55, Nro 4, 2012, s. 915-925.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

AU - Eliasson, Björn

AU - Möller-Goede , D

AU - Eeg-Olofsson, K

AU - Wilson, D

AU - Cederholm, J

AU - Fleck, P

AU - Diamant, M

AU - Taskinen, Marja-Riitta

AU - Smith, Ulf

PY - 2012

Y1 - 2012

KW - 3121 Internal medicine

U2 - 10.1007/s00125-011-2447-3

DO - 10.1007/s00125-011-2447-3

M3 - Article

VL - 55

SP - 915

EP - 925

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 4

ER -